天眼查App显示，近日，四川之江小象医疗科技有限公司成立，法定代表人为杨平号，注册资本1000万 人民币，由四川数智小象科技有限公司全资持股。 序号股东名称持股比例1四川数智小象科技有限公司100% 经营范围含技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广；信息系统集成服务；网 络与信息安全软件开发；移动终端设备销售；通讯设备销售；电子产品销售；物联网技术服务；信息技 术咨询服务；数据处理服务；国内贸易代理；货物进出口；智能控制系统集成；国内货物运输代理；卫 星移动通信终端销售；第一类医疗器械销售；医用口罩批发；医用口罩零售；医护人员防护用品批发； 医护人员防护用品零售；日用口罩（非医用）销售；劳动保护用品销售；特种劳动防护用品销售；第二 类医疗设备租赁；第一类医疗设备租赁；移动通信设备销售；健康咨询服务（不含诊疗服务）；计算机 及通讯设备租赁；计算机系统服务；软件销售；软件开发；数据处理和存储支持服务；仓储设备租赁服 务；普通货物仓储服务（不含危险化学品等需许可审批的项目）；技术进出口；第二类医疗器械销售； 护理机构服务（不含医疗服务）；人工智能基础软件开发；人工智能理论与算法软件开发；人工智能 ...

5月11日，第二十七届中国北京国际科技产业博览会（简称"北京科博会"）成功闭幕。以"科技引领创享未来"为主题，本届科博会设有信息科技、智能制 造、医药健康、绿色双碳、数字经济和区域创新6个专题展区，吸引了800余家中外企业和机构参展。 在本届北京科博会上，多项创新成果展出。其中，AI技术与医疗健康的深度融合成为亮点，智能手术机器人正助力提升基层医疗水平，更精准、稳定的疼 痛管理得以实现。我国医疗产业自主可控进展显著，部分企业实现全产业链国产化，另一些则在关键技术上突破国外垄断。"中国智造"不仅在国内大放异 彩，更在国际舞台上展现出强大的竞争力。 AI融入医疗健康：手术机器人加持基层医疗 疼痛管理更精准 北京科博会期间，多款融合了AI技术的创新医疗器械惊艳亮相。 亦庄展区内，强联智创(北京)科技有限公司的展位上，手术模拟器展示了在神经介入手术中，使用AI导管塑形机器人进行塑形后的微导管在脑血管模型中进 行模拟手术操作的过程。 北京科博会上，强联智创展出的导管塑形机器人。 强联智创董事长助理曾烨对贝壳财经记者介绍，神经介入手术在外科手术中难度极大，建立通路需对耗材进行预塑形，以往全靠医生凭经验想象完成，现在 手术 ...

Important Market News - The high-level economic and trade talks between China and the U.S. were held in Geneva from May 10 to 11, resulting in substantial progress and important consensus on mutual economic concerns [1] Industry Insights - On May 11, the humanoid robot startup Songyan Power launched a new generation of bionic robot named Xiao Nuo, featuring multi-modal interaction and near-human facial expressions. The company has already secured over 1,000 orders for its N2 robot, which has gained attention for its performance in various terrains [2] - The introduction of 5G-A technology is being noticed by consumers in cities like Beijing and Shanghai, enhancing communication capabilities significantly compared to 5G. The expected investment in 5G-A in China is projected to reach 120 billion yuan by 2025, driving growth in related industries [3] - A new online platform for "brain-computer interface patents and intellectual property" was launched at the 2025 Pujiang Innovation Forum, marking a significant step in the commercialization of brain-computer interface technology, with a market potential projected to reach $150 billion by 2040 [4] - The State Council approved the draft of the "Regulations on Government Data Sharing," aiming to enhance public service efficiency and promote the integration of data resources, which is expected to benefit cloud computing and big data platform companies [5][6] Risk Alerts - Xi'an Qujiang Cultural Tourism announced that its major shareholder's 12 million shares will be auctioned, representing 10.48% of its holdings and 4.7% of the company's total shares, although this will not affect the company's operations [7] - Keli Ke plans to reduce its shareholding by up to 14.647 million shares, accounting for 3% of the total shares, while other executives also plan to sell a small percentage of their shares [8]

"健养安-安心股养"签约仪式。 深圳赛陆医疗科技有限公司作为建设银行"健养安-安心股养"首批签约拟上市企业，立足世界科技前沿，以国家战略需求为指导，自主创新为核心动力，全 力推动基因测序和空间组学技术的革新与发展，是国产基因测序仪领军企业，获深创投等知名创投机构投资。建行深圳市分行结合企业持股平台架构及上市 进程，为企业量身定制"股权激励+上市服务+金融授信"综合服务方案，为科创企业提供全链条、场景化的养老金融服务。 在当天的揭牌仪式上，建行深圳市分行邀请深圳市慈善会执行副会长、八卦岭社区书记及银发客户共同为建行深圳市八卦岭支行揭牌。至此，深圳地区已挂 牌2家"健养安"养老金融特色网点，深圳建行养老金融服务体系再升级。 转自：新华财经 5月8日，中国建设银行在福建省福州市举办"健养安"养老金融特色网点扩容升级发布会暨养老金融产品服务推介会，并集中揭牌全国第二批"健养安"养老金 融特色网点。建设银行副行长纪志宏出席活动并致辞。中国建设银行深圳市分行（以下简称建行深圳市分行）资深副经理刘星，深圳赛陆医疗科技有限公司 联合创始人、CTO刘二凯参加"健养安-安心股养"股权激励增值服务现场签约。建行深圳市分行第二批"健 ...

Group 1: Robotics Innovations - The "Tiangong" robot, showcased at the Yizhuang exhibition area, is the world's first "human-machine co-running" half marathon champion, with its sibling "Tiangong 2.0" set to be released, featuring advanced capabilities for complex terrain navigation [1] - The Walker S1 humanoid robot from UBTECH is designed for general tasks, utilizing advanced technologies such as multimodal planning and semantic VSLAM, enhancing its agility and intelligence for industrial applications [1] Group 2: Medical Technology Advancements - Changmu Valley Medical Technology Co., Ltd. introduced the ROPA orthopedic intelligent surgical robot system, which is the first to achieve "integrated diagnosis and treatment" in orthopedic AI surgery, addressing the dependency on imported technologies [2] Group 3: Aerospace and Quantum Computing Breakthroughs - Beijing Xingtu Zhili Technology Co., Ltd. launched the "Netling Satellite Internet Terminal," the first domestically produced satellite communication device for civilian use, which was successfully deployed during the 2025 Myanmar earthquake rescue [2] - The new generation coherent optical quantum computer from Beijing Boson Quantum Technology Co., Ltd. has surpassed the 1000-bit scale, offering exponential computational power compared to classical computers, significantly reducing processing time in drug discovery [3] Group 4: Overall Impact of the Expo - The Beijing International Science and Technology Industry Expo serves as a platform for showcasing technological achievements, facilitating the transformation of scientific results and promoting collaborative industrial development [3]

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 会议召开时间：2025年05月16日(星期五) 下午 13:15-14:45 ● 会议参与方式一：上海证券交易所上证路演中心（网址：http://roadshow.sseinfo.com/）； 会议参与方式二："麦迪科技投资者关系"小程序，通过微信搜索"麦迪科技投资者关系"或微信扫一扫以 下二维码参与会议 副董事长、总经理翁康先生；独立董事李东先生；副总经理、董事会秘书李孟豪先生；财务总监梅皓先 生。 四、 投资者参加方式 （一）投资者可在2025年05月16日下午13:15-14:45，通过互联网登录上证路演中心 ● 会议召开方式：视频直播和网络互动 ● 投资者可于2025年05月09日(星期五)至05月15日(星期四)16:00前登录上证路演中心网站首页点击"提问 预征集"栏目或通过公司邮箱suzhoumedi001@medicalsystem.cn进行提问。公司将在说明会上对投资者普 遍关注的问 ...

经营稳定、现金流充裕的优势，叠加目前被严重低估的市值水平，使药师帮具备明显的"烟蒂股"特征， 吸引了公募基金的重点关注。对比其他港股医疗科技公司，药师帮的估值倍数明显偏低，当前市值远低 于企业内在价值。有分析师认为，"烟蒂股"的预期空间主要体现在短期估值修复：当市场情绪改善或行 业景气度回升时，股票价格将向内在价值回归，而其中的优质企业通过经营改善，也更有机会实现长期 价值的提升。 随着国内政策持续推动基层医疗资源配置优化，药师帮等具备数字化先发优势的企业将有望进入发展快 车道。药师帮的回购增持、业绩兑现将与资金面改善形成合力，"基本面向上+估值洼地"的稀缺属性愈 加明显，中长线布局的机会点或已出现。 近日，药师帮（9885.HK）持续释放积极信号。5月7日公告显示，公司根据2024年股份回购授权，首次 回购合共300,000股股份，总代价约为210.4万港元，平均每股7.0147港元，回购股份将被注销。公司拟 于2025年10月31日前动用最多1亿元港币于公开市场回购股份。回购计划高效推进，展现公司对于自身 业绩和未来市场的正面预期。管理层也同步增持提振信心，执行董事陈飞于4月连续增持50万股（约 316. ...

【华泰计算机】HIMS：25Q1业绩超预期，复合司美风险解除，建议重点关注 25Q1业绩超预期：收入5.86亿美元，同比+111%（指引：5.2-5.4亿)；净利润4950 万美元，同比+344.7%；调整后EBITDA为9105.7万美元（指引：5500-6500 万美元），同比+181.5%，调整后EBITDA利润率15.5%。 核心指标： ①订阅用户236.6万 公司预计将在25Q2末完成之前使用复合司美格鲁肽的订阅用户向其他替代品的完全过渡，将导致Q2收入环比一次 性下降，但公司有信心在今年下半年继续保持增长势头。 #公司复合司美格鲁肽产品停售的风险将在Q2一次性释放，公司已与诺和诺德建立战略合作关系，合作品牌司美 格鲁肽，且未来有可能和更多的品牌药企建立合作关系。 【华泰计算机】HIMS：25Q1业绩超预期，复合司美风险解除，建议重点关注 25Q1业绩超预期：收入5.86亿美元，同比+111%（指引：5.2-5.4亿)；净利润4950 万美元，同比+344.7%；调整后EBITDA为9105.7万美元（指引：5500-6500 万美元），同比+181.5%，调整后EBITDA利润率15.5%。 核心 ...

Group 1 - The core business of the company is providing Clinical Information System (CIS) software and overall solutions for clinical medical management [2] - The company's main product, DoCare, covers critical areas such as operating rooms, intensive care units, pre-hospital emergency care, and in-hospital emergency services [2] - The company has a user base of over 2,400 medical institutions across 32 provinces, including nearly 1,200 tertiary hospitals [2] Group 2 - As of March 31, 2025, the number of shareholders increased by 11,318 to a total of 48,361, with an average holding value of 352,800 yuan per shareholder [1] - The latest financial report for Q1 2025 shows a revenue of 63.34 million yuan, a year-on-year decrease of 43.13%, while net profit increased by 138.55% to 23.60 million yuan [3] - The company has a current market capitalization of 4.554 billion yuan and a price-to-book ratio of 5.53 [1][4]

Group 1: Tesla Developments - Tesla plans to release an unsupervised version of its Full Self-Driving (FSD) feature within a few months, with testing starting in Austin in June and rapid rollout across the U.S. [4] - The company aims for future manual driving to become as rare as horseback riding, indicating a significant shift in transportation norms [4] Group 2: Robotics and AI Innovations - Tesla is developing a humanoid robot named Optimus, which is expected to assist individuals in various tasks, representing a substantial market opportunity [4] - The AI system Grok has been developed to perform complex analyses accurately, emphasizing the importance of instilling a truth-seeking value in AI for safety [9] Group 3: SpaceX and Multiplanetary Goals - SpaceX focuses on rocket launches and Starlink internet operations, with ambitions to develop technologies that enable human survival on other planets, particularly Mars [6] Group 4: Neuralink's Medical Advancements - Neuralink is working on a brain-machine interface device called "Mind Reading," allowing paralyzed patients to control devices using thoughts, with current users able to communicate via the X platform [6] - A second device, "Blind Vision," aims to restore sight to blind individuals by connecting directly to the visual cortex, with initial surgeries expected within the next year [8] - The company is optimistic about enabling individuals with spinal cord injuries to regain mobility by bridging signals from the brain to damaged areas of the spine [8] Group 5: Legacy and Vision - The company aims to leave a legacy of advancing civilization, enhancing knowledge, and helping humanity understand the universe [11]